Metastatic adenocarcinoma of unknown primary origin

被引:65
|
作者
Hammar, SP [1 ]
机构
[1] Special Diagnost Lab, Bremerton, WA 98310 USA
关键词
metastatic; adenocarcinomas; neoplasms; unknown origin; electron microscopy; immunohistochemistry;
D O I
10.1016/S0046-8177(98)90007-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Adenocarcinomas account for up to 60% of all metastatic neoplasms of unknown primary origin. In general, adenocarcinomas are the most difficult metastatic tumor to accurately identify the primary site. Some metastatic adenocarcinomas have distinctive histological features that allow for their site determination (eg colonic adenocarcinoma, bronchioloalveolar cell carcinoma), although the majority of metastatic adenocarcinomas have histological features that are not distinctive enough to allow for a specific diagnosis of their origin. For this reason, electron microscopy and immunohistochemistry have been used to help identify the exact type (origin) of metastatic adenocarcinomas. Relatively specific ultrastructural features used to diagnose metastatic adenocarcinomas of unknown primary origin include tubular myelin, intranuclear surfactant apoprotein tubular inclusions, Clara cell granules, uniform short microvilli with filamentous cores and core rootlets, Langerhans cells associated with neoplastic cells, cytoplasmic hyaline globules, lipid droplets, glycogen, and cytoplasmic crystals. Only a few of these ultrastructural features are absolutely specific. Relatively specific immunohistochemical tests used to diagnose metastatic adenocarcinomas of unknown primary origin include prostate-specific antigen, thyroglobulin, estrogen and progesterone receptor proteins, thyroid transcription factor-I, and surfactant apoproteins. Of these, prostate-specific antigen and thyroglobulin are the most specific. The purpose of this article is to discuss the use of electron microscopy and immunohistochemistry in the site-specific diagnosis of metastatic adenocarcinomas of unknown primary origin. HUM PATHOL 29:1393-1402. Copyright (C) 1998 by W.B. Saunders Company.
引用
下载
收藏
页码:1393 / 1402
页数:10
相关论文
共 50 条
  • [1] METASTATIC ADENOCARCINOMA OF UNKNOWN ORIGIN
    VANNETZEL, JM
    COLBERT, N
    LAUGIER, A
    ANNALES DE MEDECINE INTERNE, 1985, 136 (05): : 423 - 429
  • [2] CUTANEOUS METASTATIC ADENOCARCINOMA OF GALLBLADDER ORIGIN PRESENTING AS CARCINOMA OF UNKNOWN PRIMARY
    KRUNIC, A
    MARTINOVIC, N
    CALONJE, E
    MILINKOVIC, M
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (05) : 360 - 362
  • [3] CHEMOTHERAPY OF METASTATIC ADENOCARCINOMA OF UNKNOWN ORIGIN
    NELSON, RB
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (25): : 1478 - 1478
  • [4] Multiple nodules on the face and trunk in metastatic adenocarcinoma of unknown primary origin
    Furtado, S.
    Bhat, R. M.
    Sukumar, D.
    Krishnamurthy, S. G.
    Rao, S. D.
    Nandakishore, B.
    SINGAPORE MEDICAL JOURNAL, 2011, 52 (07) : E163 - E166
  • [5] CHEMOTHERAPY OF METASTATIC ADENOCARCINOMA OF UNKNOWN ORIGIN - REPLY
    WOODS, RL
    FOX, RM
    TATTERSALL, MHN
    LEVI, JA
    BRODIE, GN
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (25): : 1479 - 1479
  • [6] Metastatic Melanoma of Unknown Primary Origin
    Ahmed, H. M.
    Warnick, J.
    Bagwan, I.
    JOURNAL OF PATHOLOGY, 2022, 256 : S13 - S13
  • [7] METASTATIC TUMORS OF UNKNOWN PRIMARY ORIGIN
    HAMMAR, S
    BOCKUS, D
    REMINGTON, F
    LABORATORY INVESTIGATION, 1990, 62 (01) : A112 - A112
  • [8] Metastatic malignancies of unknown primary site and malignancies of unknown origin whether primary or metastatic
    Al-Hilli, F
    Ansari, NA
    SAUDI MEDICAL JOURNAL, 2005, 26 (11) : 1840 - 1843
  • [9] Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site
    Li, Xinrong
    Shao, Yan
    Sheng, Liqiang
    Zhu, Junquan
    Wang, Zeming
    Guo, Kaibo
    Sun, Leitao
    CANCER MEDICINE, 2021, 10 (03): : 974 - 988
  • [10] THE MANAGEMENT OF METASTATIC ADENOCARCINOMA FROM UNKNOWN PRIMARY
    LEVI, JA
    WOODS, RL
    FOX, RM
    TATTERSALL, MHN
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1984, 14 (06): : 951 - 952